Investigational Drug Information for Palifosfamide
✉ Email this page to a colleague
« Back to Dashboard
▶ Start for $1
Remove trial restrictions
What is the development status for investigational drug Palifosfamide?
Palifosfamide is an investigational drug.
There have been 8 clinical trials for Palifosfamide. The most recent clinical trial was a Phase 3 trial, which was initiated on May 1st 2012.
The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Testicular Neoplasms. The leading clinical trial sponsors are Ziopharm, Indiana University School of Medicine, and [disabled in preview].
Summary for Palifosfamide
|US Patent Applications||371|
|WIPO Patent Applications||237|
|Japanese Patent Applications||99|
|Clinical Trial Progress||Phase 3 (2012-05-01)|
Recent Clinical Trials for Palifosfamide
|Adenoviral Vector Monotherapy or Combination With Chemotherapy in Subjects With Recurrent/Metastatic Breast Cancer.||Ziopharm||Phase 2|
|Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors||Ziopharm||Phase 2|
|Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors||Indiana University School of Medicine||Phase 2|
Clinical Trial Summary for Palifosfamide
Top disease conditions for Palifosfamide
Top clinical trial sponsors for Palifosfamide
US Patents for Palifosfamide
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|